EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Cardiopulmonary Events of the Elderly (≥75 Years) during Clazosentan Therapy after Subarachnoid Hemorrhage: A Retrospective Study from a Tertiary Stroke Center in Japan

Tatsushi Mutoh iD, Hiroaki Aono, Wataru Seto, Takehiro Kimoto, Ryota Tochinai iD, Junta Moroi, Tatsuya Ishikawa

Medicina · 2024

DOI: 10.3390/medicina60010185 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Medicina, 2024. Verfasst von Tatsushi Mutoh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Neurology, Research Institute for Brain and Blood Vessels, Akita Cerebrospinal and Cardiovascular Center, Akita 010-0874, Japa…. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Vasospasm, Intracranial, Stroke, Pyrimidines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clazosentan has been shown to prevent vasospasm and reduce mortality in patients after aneurysmal subarachnoid hemorrhage (SAH) and has been approved for clinical use in Japan; however, its systemic events in the elderly (aged ≥ 75 years) have not been well-documented. Here, we report serious/intolerable cardiopulmonary complications requiring discontinuation of drug therapy in elderly SAH patients. In this single-center case series study, medical records of consecutive SAH patients treated postoperatively with clazosentan (10 mg/h) between June 2022 and May 2023 were reviewed retrospectively. Thirty-three patients received clazosentan therapy, of whom six were elderly with a mean age of 80.3 ± 5.2 (range 75–89) years. Among them, despite no obvious medical history of systemic abnormalities, clazosentan was discontinued in three (50%) patients due to pleural effusion and hypoxemia with or without hypotension at 5 ± 3 days after therapy initiation, which was higher than the incidence for younger patients (15%). The elderly patients had significantly lower urine output (1935 ± 265 vs. 1123 ± 371 mL/day, p = 0.03) and greater weight gain (2.1 ± 1.1 vs. 4.2 ± 1.9 kg from baseline, p = 0.04) than patients who completed the therapy. One 89-year-old female developed congestive heart failure and hydrostatic pulmonary edema associated with increased intravascular and lung volumes even after therapy was discontinued, while the remaining two cases recovered within 2 days after drug cessation. These results suggest that elderly patients are more vulnerable to fluid retention and have a higher risk of cardiopulmonary complications during clazosentan therapy than younger patients. Careful monitoring of urine volume and weight gain and caution regarding age- and therapy-related hemodynamic insufficiencies are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Subarachnoid HemorrhageVasospasm, IntracranialStrokePyrimidinesPyridinesDioxanesSulfonamidesTetrazolesAgedFemaleHumansAged, 80 and overRetrospective StudiesJapanWeight Gain

Stichwörter der Autor:innen

cerebral vasospasmclazosentanelderlysubarachnoid hemorrhagesystemic events

Substanzen

clazosentanPyrimidinesPyridinesDioxanesSulfonamidesTetrazoles

Autor:innen und Institutionen

  • Department of Surgical Neurology, Research Institute for Brain and Blood Vessels, Akita Cerebrospinal and Cardiovascular Center, Akita 010-0874, Japan.
  • Department of Aging Research and Geriatric Medicine, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.
  • Department of Pharmaceutics, Akita Cerebrospinal and Cardiovascular Center, Akita 010-0874, Japan.
  • Department of Veterinary Pathophysiology and Animal Health, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8654, Japan.

ORCID-Profile: Tatsushi Mutoh, Ryota Tochinai

Zitieren

APA

Mutoh, T., Aono, H., Seto, W., Kimoto, T., Tochinai, R., Moroi, J., & Ishikawa, T. (2024). Cardiopulmonary Events of the Elderly (≥75 Years) during Clazosentan Therapy after Subarachnoid Hemorrhage: A Retrospective Study from a Tertiary Stroke Center in Japan. Medicina. https://doi.org/10.3390/medicina60010185

Vancouver

Mutoh T, Aono H, Seto W, Kimoto T, Tochinai R, Moroi J, et al. Cardiopulmonary Events of the Elderly (≥75 Years) during Clazosentan Therapy after Subarachnoid Hemorrhage: A Retrospective Study from a Tertiary Stroke Center in Japan. Medicina. 2024. doi:10.3390/medicina60010185

BibTeX
@article{Mutoh2024,
  author = {Mutoh, Tatsushi and Aono, Hiroaki and Seto, Wataru and Kimoto, Takehiro and Tochinai, Ryota and Moroi, Junta and Ishikawa, Tatsuya},
  title = {Cardiopulmonary Events of the Elderly (≥75 Years) during Clazosentan Therapy after Subarachnoid Hemorrhage: A Retrospective Study from a Tertiary Stroke Center in Japan},
  journal = {Medicina},
  year = {2024},
  doi = {10.3390/medicina60010185}
}
Kostenlos starten →